GRI强调IPF安全性优势与肺功能改善,面临资金紧张挑战。
GRI touts IPF safety edge, lung function gains amid cash crunch
生物技术与制药领域的最新动态
GRI touts IPF safety edge, lung function gains amid cash crunch
Zealand pens $2.5B oral cardiometabolic collab with fresh-faced Chinese biotech
FDA approves 1st nondrug, at-home treatment for depression
Lilly’s triple agonist posts strongest weight loss data yet, unusual skin side effect also reported
Citigroup Upgrades Thermo Fisher Scientific to Buy From Neutral, Adjusts PT to $660 From $580 - marketscreener.com
House backs Biosecure Act aimed at Chinese companies
What Is Happening With Thermo Fisher Scientific Stock? - Trefis
Apple Tree Partners files for bankruptcy to keep cash flowing to portfolio biotechs
Francis Medical gets FDA green light for water vapor ablation to treat prostate cancer
Bleecker's big bang: Formation Bio unveils new subsidiary with $605M Lynk deal
Sanofi, GSK ink preclinical pacts in quest for new autoimmune and cancer antibodies
Investors buy up stocks in biggest follow-on offering day in biotech history
Apple Tree files for bankruptcy as it seeks funds from Russian billionaire backer
USAntibiotics scores sped-up approval for amoxicillin
Waters Corporation (WAT) Upgraded by Wolfe Research Amid Merger Potential - GuruFocus
In the clinic for Dec. 10, 2025
The BioWorld Insider podcast: Finding a better, longer-lasting fix in opioid overdose
D3 Bio raises $108M series B to move KRAS G12C into phase III
Appointments and advancements for Dec. 10, 2025
Financings for Dec. 10, 2025